Presence of Tissue Transglutaminase in Granular Endoplasmic Reticulum is Characteristic of Melanized Neurons in Parkinson's Disease Brain

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Brain Pathology

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1750-3639.2010.00429.xPMID 20731657PMCID PMC8094245
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Novel role of transglutaminase 1 in corpora amylacea formation?

  2011cited by this paper
• Mitochondrial Dysfunction in Parkinson's Disease

  2011cited by this paper
• Heat shock proteins

  2011cited by this paper
• Transglutaminase 2: a multi-functional protein in multiple subcellular compartments

  2010cited by this paper
• Protein Targets of Oxidative Damage in Human Neurodegenerative Diseases with Abnormal Protein Aggregates

  2010cited by this paper
• Mitochondrial dysfunction in Parkinson's disease.

  2010cited by this paper
• Dissecting the mechanisms of tissue transglutaminase-induced cross-linking of alpha-synuclein: implications for the pathogenesis of Parkinson disease.

  2009cited by this paper
• Transglutaminases and Transglutaminase‐Catalyzed Cross‐Links Colocalize with the Pathological Lesions in Alzheimer's Disease Brain

  2009cited by this paper
• Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum.

  2009cited by this paper
• Transglutaminase-mediated Intramolecular Cross-linking of Membrane-bound α-Synuclein Promotes Amyloid Formation in Lewy Bodies*

  2009influential reference
• Tissue transglutaminase: a novel pharmacological target in preventing toxic protein aggregation in neurodegenerative diseases.

  2008cited by this paper
• Tissue transglutaminase modulates α‐synuclein oligomerization

  2008cited by this paper
• Transglutaminase Induces Protofibril-like Amyloid β-Protein Assemblies That Are Protease-resistant and Inhibit Long-term Potentiation*

  2008cited by this paper
• Coping with loss of perfection in the MHC class I peptide repertoire.

  2008cited by this paper
• TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

  2008cited by this paper
• Cell Stress Induced by the Parkinsonian Mimetic, 6-Hydroxydopamine, is Concurrent with Oxidation of the Chaperone, ERp57, and Aggresome Formation

  2007cited by this paper
• Activation of the unfolded protein response in Parkinson's disease.

  2007cited by this paper
• ER chaperones in mammalian development and human diseases

  2007influential reference
• Cell-surface transglutaminase undergoes internalization and lysosomal degradation: an essential role for LRP1

  2007cited by this paper
• Expanding Insights on the Involvement of Endoplasmic Reticulum Stress in Parkinson's Disease

  2007cited by this paper
• Tissue transglutaminase and the stress response

  2007cited by this paper
• The role of tissue transglutaminase in 1-methyl-4-phenylpyridinium (MPP+)-induced toxicity in differentiated human SH-SY5Y neuroblastoma cells.

  2006cited by this paper
• The release of Hsp70 from A431 carcinoma cells is mediated by secretory-like granules.

  2006cited by this paper
• Tau Protein Is Cross-Linked by Transglutaminase in P301L Tau Transgenic Mice

  2005cited by this paper
• Cellular functions of endoplasmic reticulum chaperones calreticulin, calnexin, and ERp57.

  2005cited by this paper
• Tissue transglutaminase catalyzes the formation of alpha‐synuclein crosslinks in Parkinson's disease

  2004cited by this paper
• Tissue Transglutaminase Is a Multifunctional BH3-only Protein*

  2004cited by this paper
• Effect of tissue transglutaminase on the solubility of proteins containing expanded polyglutamine repeats

  2004cited by this paper
• Proteomic analysis of exosomes secreted by human mesothelioma cells.

  2004cited by this paper
• Parkinsonian Mimetics Induce Aspects of Unfolded Protein Response in Death of Dopaminergic Neurons*

  2003cited by this paper
• Heat‐Shock Proteins

  2003cited by this paper
• Transglutaminases: crosslinking enzymes with pleiotropic functions

  2003cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Proteomics Identification of Acyl-acceptor and Acyl-donor Substrates for Transglutaminase in a Human Intestinal Epithelial Cell Line

  2003cited by this paper
• Tissue transglutaminase-induced aggregation of α-synuclein: Implications for Lewy body formation in Parkinson's disease and dementia with Lewy bodies

  2003influential reference
• Proteomic analysis reveals upregulation of calreticulin in murine dopaminergic neuronal cells after treatment with 6-hydroxydopamine.

  2003cited by this paper
• Transglutaminase Cross‐Links in Intranuclear Inclusions in Huntington Disease

  2003cited by this paper
• Evidence for a role for transglutaminase in Huntington's disease and the potential therapeutic implications.

  2002cited by this paper
• Transglutaminase bonds in neurofibrillary tangles and paired helical filament tau early in Alzheimer's disease.

  2002cited by this paper
• Transglutaminase 2: an enigmatic enzyme with diverse functions.

  2002cited by this paper
• Integrin signaling regulates blastocyst adhesion to fibronectin at implantation: intracellular calcium transients and vesicle trafficking in primary trophoblast cells.

  2002cited by this paper
• A novel quality control compartment derived from the endoplasmic reticulum.

  2001influential reference
• Neuropathology of synuclein aggregates

  2000cited by this paper
• Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II.

  1999cited by this paper
• KDEL proteins are found on the surface of NG108-15 cells.

  1999cited by this paper
• Tissue Transglutaminase Is Increased in Huntington's Disease Brain

  1999cited by this paper
• Elevated transglutaminase-induced bonds in PHF tau in Alzheimer's disease.

  1999cited by this paper
• Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine.

  1998cited by this paper
• Ubiquitin, cellular inclusions and their role in neurodegeneration.

  1998cited by this paper
• Tissue transglutaminase-catalyzed formation of high-molecular-weight aggregates in vitro is favored with long polyglutamine domains: a possible mechanism contributing to CAG-triplet diseases.

  1998cited by this paper
• Transglutaminase Cross‐Linking of the τ Protein

  1995cited by this paper
• Transglutaminase cross-linking of the tau protein.

  1995cited by this paper
• Tissue transglutaminase and apoptosis: sense and antisense transfection studies with human neuroblastoma cells

  1994cited by this paper
• Biochemical events in naturally occurring forms of cell death

  1993cited by this paper
• Activity and Distribution of Tissue Transglutaminase in Association with Nerve‐Muscle Synapses

  1993cited by this paper
• Mitochondrial Complex I Deficiency in Parkinson's Disease

  1989cited by this paper
• Lipids associated with tissue transglutaminase.

  1987cited by this paper
• Interaction between tissue transglutaminase and phospholipid vesicles

  1983cited by this paper
• Neurochemical studies on the inverted laminar cerebral cortex of the reeler mutant mouse

  1979cited by this paper

• Posttranslational Modifications of α-Synuclein, Their Therapeutic Potential, and Crosstalk in Health and Neurodegenerative Diseases

  2024cites this paper
• Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors

  2024cites this paper
• Tissue Transglutaminase: A Multifunctional and Multisite Regulator in Health and Disease.

  2023cites this paper
• Aberrant expression of transglutaminase 2 in pancreas and thymus of NOD mice underscores the importance of deamidation in neoantigen generation

  2022cites this paper
• Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease

  2022cites this paper
• Differential Response to Three Antidepressants in Patients with Major Depressive Episode Who Suffered Covid-19-Related Trauma

  2022cites this paper
• Pre-clinical Studies Identifying Molecular Pathways of Neuroinflammation in Parkinson's Disease: A Systematic Review

  2022cites this paper
• Transglutaminase 2 as a therapeutic target for neurological conditions

  2021cites this paper
• The Protein Disulfide Isomerase Family: from proteostasis to pathogenesis.

  2020cites this paper
• Transglutaminase 2 Depletion Attenuates α-Synuclein Mediated Toxicity in Mice

  2020cites this paper
• Dietary Gluten and Neurodegeneration: A Case for Preclinical Studies

  2020cites this paper
• Candesartan Neuroprotection in Rat Primary Neurons Negatively Correlates with Aging and Senescence: a Transcriptomic Analysis

  2019cites this paper
• 15(V/K) kinetic isotope effect and steady-state kinetic analysis for the transglutaminase 2 catalyzed deamidation and transamidation reactions.

  2018cites this paper
• New insight into transglutaminase 2 and link to neurodegenerative diseases

  2018cites this paper
• Inflammatory mediators resulting from transglutaminase 2 expressed in mast cells contribute to the development of Parkinson's disease in a mouse model

  2018cites this paper
• Opening up about Tissue Transglutaminase: When Conformation Matters More than Enzymatic Activity

  2018influential citation
• Elevated transglutaminase‐2 expression in the epidermis of psoriatic skin and its role in the skin lesion development

  2017cites this paper
• Organogenesis: From Development to Disease

  2017cites this paper
• Environmental Factors Contribute to β Cell Endoplasmic Reticulum Stress and Neo-Antigen Formation in Type 1 Diabetes

  2017cites this paper
• Molecular changes in the postmortem parkinsonian brain

  2016cites this paper
• Is monocyte- and macrophage-derived tissue transglutaminase involved in inflammatory processes?

  2016cites this paper
• Chapter 2 Tissue transglutaminase colocalises with extracellular matrix proteins in cerebral amyloid angiopathy

  2016cites this paper
• Development of carbon-11 labeled acryl amides for selective PET imaging of active tissue transglutaminase.

  2016cites this paper
• Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer’s disease mouse models

  2016cites this paper
• Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes.

  2016cites this paper
• β cell ER stress and the implications for immunogenicity in type 1 diabetes

  2015cites this paper
• Transglutaminase 2 is involved in homocysteine-induced activation of human THP-1 monocytes

  2015cites this paper
• Tumor progression and the Different Faces of the PERK kinase

  2015cites this paper
• T Cell Epitopes and Post-Translationally Modified Epitopes in Type 1 Diabetes

  2015cites this paper
• Parkinson’s Disease; Neurodegeneration as Systemic Disease

  2015cites this paper
• Transglutaminases and Neurological Diseases

  2015cites this paper
• 5‐S‐cysteinyldopamine neurotoxicity: Influence on the expression of α‐synuclein and ERp57 in cellular and animal models of Parkinson's disease

  2014cites this paper
• Tissue Transglutaminase in Alzheimer's Disease: Involvement in Pathogenesis and its Potential as a Therapeutic Target

  2014cites this paper
• Neuropathology of Parkinson’s Disease

  2014cites this paper
• Developmental Exposure to a Commercial PBDE Mixture: Effects on Protein Networks in the Cerebellum and Hippocampus of Rats

  2014cites this paper
• Tissue transglutaminase is a biochemical marker for Alzheimer's disease.

  2014cites this paper
• Transglutaminase 2 exacerbates α‐synuclein toxicity in mice and yeast

  2014cites this paper
• Parkinson ’ s disease is associated with altered expression of CaV 1 channels and calcium-binding proteins

  2013cites this paper
• Parkinson's disease is associated with altered expression of CaV1 channels and calcium-binding proteins.

  2013cites this paper
• Transglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E

  2013cites this paper
• Tissue transglutaminase cross-links beclin 1 and regulates autophagy in MPP⁺-treated human SH-SY5Y cells.

  2013cites this paper
• Tissue transglutaminase colocalizes with extracellular matrix proteins in cerebral amyloid angiopathy.

  2013cites this paper
• Increase in endoplasmic reticulum-associated tissue transglutaminase and enzymatic activation in a cellular model of Parkinson's disease.

  2012cites this paper
• Tianma modulates proteins with various neuro-regenerative modalities in differentiated human neuronal SH-SY5Y cells.

  2012cites this paper
• Detection of Transglutaminase 2 conformational changes in living cell.

  2012cites this paper
• Transglutaminase 1 and its regulator tazarotene‐induced gene 3 localize to neuronal tau inclusions in tauopathies

  2012cites this paper
• α Aggregation and Modulating Factors

  2012cites this paper
• Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

  2012cites this paper
• Transglutaminase 2: biology, relevance to neurodegenerative diseases and therapeutic implications.

  2012cites this paper
• Role of ER Stress in Dysfunction of the Nervous System

  2012cites this paper
• The role of α-synuclein in neurodegeneration — An update

  2012cites this paper
• α-Synuclein aggregation and modulating factors.

  2012cites this paper
• Gastrodia elata Blume (tianma) mobilizes neuro-protective capacities.

  2012cites this paper
• Proteomic insights into the protective mechanisms of an in vitro oxidative stress model of early stage Parkinson's disease.

  2011cites this paper
• γ-Glutamylamines and neurodegenerative diseases

  2011cites this paper
• Apolipoprotein E and LRP1 Increase Early in Parkinson's Disease Pathogenesis.

  2011cites this paper